Dualsystems Biotech AG

Dualsystems Biotech AG is a Swiss biotech company founded in 2000. Dualsystems Biotech AG successfully introduced the yeast two-hybrid technology to the market and has been at the forefront of expanding its application areas. In recent years, mass spectrometry-based proteomics technology has become one of the main pillars of the company's expertise. The company is currently focusing on its mass spectrometer-based CaptiVate and captierc technologies.